Latest:
Resistance Mechanisms and Molecular Testing in ALK Inhibitor–Treated NSCLC
Panelists discuss mechanisms of acquired resistance to ALK inhibition and how molecular testing guides sequencing strategies.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Alexey V. Danilov, MD, PhD
Alexey Danilov, MD, PhD, is the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope
Latest:
Dr Danilov on Considerations in Frontline Treatment Selection for CLL
Alexey Danilov, MD, PhD, discusses frontline treatment selection for chronic lymphocytic leukemia.
Alexis E. Horace, PharmD
Latest:
The Future of Melanoma Treatment
Drugs currently approved by the FDA for treatment of melanoma include aldesleukin, dabrafenib, dacarbazine, ipilimumab, trametinib, and vemurafenib. This article will explore pharmacologic agents currently being investigated for the treatment of melanoma.
Alfred L. Garfall, MD, MS
Alfred L. Garfall, MD, MS, is an associate professor of medicine (hematology-oncology) and director of the Autologous Hematopoietic Cell Transplantation, Cell Therapy and Transplant Program at Hospital of the University of Pennsylvania. He is also section chief of Multiple Myeloma in the Division of Hematology/Oncology, in the Department of Medicine, at Perelman School of Medicine, of University of Pennsylvania.
Latest:
Dr Garfall on the Rationale of the Phase 2 BMT CTN 1902 Trial in Myeloma
Alfred L. Garfall, MD, MS, discusses the rationale of the phase 2 BMT CTN 1902 trial in multiple myeloma.
Ali Sadoughi, MD
Latest:
"Ultrathin" Bronchoscopy Improves Care for Patients With Lung Nodules
To spare patients from surgery or other unnecessary procedures, Montefiore Einstein Center for Cancer Care developed an advanced method of bronchoscopy that provides peace of mind for individuals with lung nodules. The minimally invasive bronchoscopy provides a very safe method of biopsy, importantly at very early stages when the nodules are relatively small.
Alice Goodman
Latest:
Small Renal Masses in Elderly Can Be Managed by Surveillance
Small renal masses identified in elderly patients can be safely managed by surveillance and maintain the same mortality risk as those who undergo surgery, suggesting that surgery could be avoided altogether in many patients.
Alice Mims, MD
Latest:
Dr. Mims on FDA Approval of Ivosidenib in Patients With AML
Alice Mims, MD, medical oncologist, Department of Internal Medicine, Division of Hematology, Ohio State University Comprehensive Cancer Center, discusses the FDA approval of the IDH1m inhibitor ivosidenib for the treatment of patients with acute myeloid leukemia (AML).